Literature DB >> 18440515

Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization.

Lubna Pal1, Sangita Jindal, Barry R Witt, Nanette Santoro.   

Abstract

OBJECTIVE: To determine if attempts to maximize oocyte yield during ovarian stimulation translates into improved outcome of in vitro fertilization (IVF) cycles.
DESIGN: Retrospective study.
SETTING: Academic tertiary care IVF center. PATIENT(S): 806 de-identified nondonor IVF cycles. INTERVENTION(S): Evaluation of fresh nondonor IVF cycles (n = 806) for the period January 1, 1999, to December 30, 2001. MAIN OUTCOME MEASURE(S): Cycle cancellation, clinical pregnancy, spontaneous miscarriage, and live birth after IVF. RESULT(S): Advancing age, independent of ovarian reserve status (reflected by early follicular phase FSH and estradiol) augured a worse prognosis for all outcomes. Higher gonadotropin use lowered cycle cancellations but was associated with a statistically significantly reduced likelihood of clinical pregnancy and live birth and a trend toward a higher likelihood for spontaneous miscarriage after IVF. CONCLUSION(S): Our data add to the accruing literature suggesting adverse influences of excess gonadotropin use on IVF outcomes. Although an aggressive approach to controlled ovarian hyperstimulation results in a statistically significant reduction in cycle cancellations, the excessive use of gonadotropins detrimentally influences live birth after IVF.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18440515      PMCID: PMC2601677          DOI: 10.1016/j.fertnstert.2007.05.055

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  24 in total

1.  Basal FSH, estradiol and inhibin B concentrations in women with a previous Down's syndrome affected pregnancy.

Authors:  J M van Montfrans; M H A van Hooff; F Martens; C B Lambalk
Journal:  Hum Reprod       Date:  2002-01       Impact factor: 6.918

2.  High basal estradiol level and FSH/LH ratio in unexplained recurrent pregnancy loss.

Authors:  Birgül Gürbüz; Serap Yalti; Selcuk Ozden; Cem Ficicioglu
Journal:  Arch Gynecol Obstet       Date:  2003-05-20       Impact factor: 2.344

3.  Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age.

Authors:  J P Toner; C B Philput; G S Jones; S J Muasher
Journal:  Fertil Steril       Date:  1991-04       Impact factor: 7.329

4.  Women with a reduced ovarian complement may have an increased risk for a child with Down syndrome.

Authors:  S B Freeman; Q Yang; K Allran; L F Taft; S L Sherman
Journal:  Am J Hum Genet       Date:  2000-03-24       Impact factor: 11.025

5.  Reproductive outcome in patients with diminished ovarian reserve.

Authors:  A J Levi; M F Raynault; P A Bergh; M R Drews; B T Miller; R T Scott
Journal:  Fertil Steril       Date:  2001-10       Impact factor: 7.329

6.  Superovulatory doses of pregnant mare serum gonadotropin cause delayed implantation and infertility in immature rats.

Authors:  B G Miller; D T Armstrong
Journal:  Biol Reprod       Date:  1981-09       Impact factor: 4.285

7.  Gonadotrophin stimulation reduces VEGF(120) expression in the mouse uterus during the peri-implantation period.

Authors:  R M Sibug; F M Helmerhorst; A M I Tijssen; E R de Kloet; J de Koning
Journal:  Hum Reprod       Date:  2002-06       Impact factor: 6.918

8.  Young age does not protect against the adverse effects of reduced ovarian reserve--an eight year study.

Authors:  Tarek El-Toukhy; Yacoub Khalaf; Roger Hart; Alison Taylor; Peter Braude
Journal:  Hum Reprod       Date:  2002-06       Impact factor: 6.918

9.  An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve.

Authors:  H Abdalla; M Y Thum
Journal:  Hum Reprod       Date:  2004-03-11       Impact factor: 6.918

10.  Age is a better predictor of pregnancy potential than basal follicle-stimulating hormone levels in women undergoing in vitro fertilization.

Authors:  Chih Chi Chuang; Chin-Der Chen; Kuang-Han Chao; Shee-Uan Chen; Hong-Nerng Ho; Yu-Shih Yang
Journal:  Fertil Steril       Date:  2003-01       Impact factor: 7.329

View more
  16 in total

1.  Prolonged gonadotropin stimulation is associated with decreased ART success.

Authors:  Meleen Chuang; Athena Zapantis; Martina Taylor; Sangita K Jindal; Genevieve S Neal-Perry; Harry J Lieman; Alex Joel Polotsky
Journal:  J Assist Reprod Genet       Date:  2010-09-07       Impact factor: 3.412

2.  Does higher starting dose of FSH stimulation with letrozole improve fertility preservation outcomes in women with breast cancer?

Authors:  Sanghoon Lee; Kutluk Oktay
Journal:  Fertil Steril       Date:  2012-07-06       Impact factor: 7.329

3.  Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles.

Authors:  Valerie L Baker; Morton B Brown; Barbara Luke; George W Smith; James J Ireland
Journal:  Fertil Steril       Date:  2015-08-18       Impact factor: 7.329

4.  Prolonged gonadotropin stimulation for assisted reproductive technology cycles is associated with decreased pregnancy rates for all women except for women with polycystic ovary syndrome.

Authors:  Amanda Ryan; Shunping Wang; Ruben Alvero; Alex J Polotsky
Journal:  J Assist Reprod Genet       Date:  2014-05-28       Impact factor: 3.412

5.  Defining ovarian reserve to better understand ovarian aging.

Authors:  Norbert Gleicher; Andrea Weghofer; David H Barad
Journal:  Reprod Biol Endocrinol       Date:  2011-02-07       Impact factor: 5.211

6.  Improvement of mouse embryo quality by myo-inositol supplementation of IVF media.

Authors:  Sandra Colazingari; Maria Teresa Fiorenza; Gianfranco Carlomagno; Robert Najjar; Arturo Bevilacqua
Journal:  J Assist Reprod Genet       Date:  2014-02-14       Impact factor: 3.412

7.  Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserve.

Authors:  Dharmawijaya N Lekamge; Michelle Lane; Robert B Gilchrist; Kelton P Tremellen
Journal:  J Assist Reprod Genet       Date:  2008-10-30       Impact factor: 3.412

8.  "Mild" vs. "long" protocol for controlled ovarian hyperstimulation in patients with expected poor ovarian responsiveness undergoing in vitro fertilization (IVF): a large prospective randomized trial.

Authors:  Alberto Revelli; Alessandra Chiadò; Paola Dalmasso; Veronica Stabile; Francesca Evangelista; Gemma Basso; Chiara Benedetto
Journal:  J Assist Reprod Genet       Date:  2014-04-04       Impact factor: 3.412

9.  The absorption and uptake of recombinant human follicle-stimulating hormone through vaginal subcutaneous injections--a pharmacokinetic study.

Authors:  Chao-Chin Hsu; Hsin-Chih Kuo; Chao-Tien Hsu; Qing Gu
Journal:  Reprod Biol Endocrinol       Date:  2009-10-07       Impact factor: 5.211

10.  Using a mild stimulation protocol combined with clomiphene citrate and recombinant follicle-stimulating hormone to determine the optimal number of oocytes needed to achieve pregnancy and reduce the concerns of patients.

Authors:  Rikikazu Sugiyama; Koji Nakagawa; Yayoi Nishi; Yuko Ojiro; Hiroyasu Juen; Rie Sugiyama; Yasushi Kuribayashi
Journal:  Reprod Med Biol       Date:  2013-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.